Trials / Completed
CompletedNCT00537901
First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- King Faisal Specialist Hospital & Research Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | First-Line Bevacizumab and Chemotherapy | Chemotherapy |
| DRUG | Bevacizumab | Chemotherapy |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2007-10-02
- Last updated
- 2015-12-17
Source: ClinicalTrials.gov record NCT00537901. Inclusion in this directory is not an endorsement.